S

Cassava Sciences
D

SAVA

2.55000
USD
-0.15
(-5.56%)
مغلق
حجم التداول
25,283
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
122,681,711
أصول ذات صلة
    A
    ACIU
    -0.01200
    (-0.45%)
    2.65000 USD
    A
    AGIO
    1.430
    (4.23%)
    35.210 USD
    A
    ANVS
    -0.09000
    (-4.05%)
    2.13000 USD
    A
    AVXL
    -0.35000
    (-4.03%)
    8.34000 USD
    BIIB
    BIIB
    3.560
    (2.60%)
    140.630 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    C
    CTSO
    0.03000
    (2.68%)
    1.15000 USD
    S
    SAVA
    -0.15000
    (-5.56%)
    2.55000 USD
    المزيد
الأخبار المقالات

العنوان: Cassava Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.